drugset / Trial / NCT02963896

Vertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular Schwannoma

NCT02963896

Completed 20 enrolled University Hospital, Motol
NaSingle-groupOpen-labelSupportive care

Summary

Surgical removal of vestibular schwannoma causes acute vestibular symptoms, including postoperative vertigo and oscilopsia due to nystagmus. In general, the dominant symptom postoperatively is vertigo. Preoperative chemical vestibular ablation can reduce vestibular symptoms postoperatively.

Timeline

Start
2014-01
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Gentamicin Small molecule 0.5 ml Other
Subject Gentamicin Small molecule 1 ml Other
Subject Gentamicin Small molecule 40 mg/ml Other

Indications